DrugDashboards

Methocarbamol Tablets, USP, 500 mg

Methocarbamol · METHOCARBAMOL 500 mg/1 · Tablet, Film Coated · Oral · Marlex Pharmaceuticals, Inc.

NDC 10135-0722-01 · 100 TABLET, FILM COATED in 1 BOTTLE · ANDA · View full market →

The short version

21 companies supply this market — deep enough that no single failure threatens the supply.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Part D plans paid (avg)$0.1538per dosage unitgross, before rebates — matched by drug name · 2024
  • Federal contracts pay (FSS)$0.0469per unitMarlex Pharmaceuticals, Inc. · Feb 1, 2025

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for methocarbamol (oral solid) in the next 90 days

sole-source market · price up 2% YoY

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA212623
TE code
AA
Approval date
Apr 30, 2021
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Methocarbamol (Tablet, Film Coated)

LabelerStrengthFirst seenLast seen
Asclemed USA, Inc.METHOCARBAMOL 750 mg/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackMETHOCARBAMOL 750 mg/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackMETHOCARBAMOL 500 mg/1Jul 15, 2026Sep 3, 2026
Preferred Pharmaceuticals Inc.METHOCARBAMOL 500 mg/1Jul 15, 2026Sep 3, 2026
Advanced Rx Pharmacy of Tennessee, LLCMETHOCARBAMOL 750 mg/1Jul 15, 2026Sep 2, 2026
Advanced Rx Pharmacy of Tennessee, LLCMETHOCARBAMOL 500 mg/1Jul 15, 2026Sep 2, 2026
Aphena Pharma Solutions - Tennessee, LLCMETHOCARBAMOL 750 mg/1Jul 15, 2026Sep 2, 2026
Asclemed USA, Inc.METHOCARBAMOL 500 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedMETHOCARBAMOL 750 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedMETHOCARBAMOL 500 mg/1Jul 15, 2026Sep 2, 2026
Fh2 Pharma LlcMETHOCARBAMOL 1000 mg/1Jul 15, 2026Sep 2, 2026
Forte Bio-PharmaMETHOCARBAMOL 1000 mg/1Jul 15, 2026Sep 2, 2026
Granulation Technology, Inc.METHOCARBAMOL 500 mg/1Jul 15, 2026Sep 2, 2026
Granulation Technology, Inc.METHOCARBAMOL 750 mg/1Jul 15, 2026Sep 2, 2026
Marlex Pharmaceuticals, Inc.METHOCARBAMOL 500 mg/1Jul 15, 2026Sep 2, 2026
Marlex Pharmaceuticals, Inc.METHOCARBAMOL 750 mg/1Jul 15, 2026Sep 2, 2026
NCS HealthCare of KY, LLC dba Vangard LabsMETHOCARBAMOL 750 mg/1Jul 15, 2026Sep 2, 2026
NCS HealthCare of KY, LLC dba Vangard LabsMETHOCARBAMOL 500 mg/1Jul 15, 2026Sep 2, 2026
NuCare Pharmaceuticals,Inc.METHOCARBAMOL 750 mg/1Jul 15, 2026Sep 2, 2026
Phoenix Rx LlcMETHOCARBAMOL 750 mg/1Jul 15, 2026Sep 2, 2026
Preferred Pharmaceuticals Inc.METHOCARBAMOL 750 mg/1Jul 15, 2026Sep 2, 2026
Proficient Rx LPMETHOCARBAMOL 750 mg/1Jul 15, 2026Sep 2, 2026
Proficient Rx LPMETHOCARBAMOL 500 mg/1Jul 15, 2026Sep 2, 2026
Redpharm DrugMETHOCARBAMOL 500 mg/1Jul 15, 2026Sep 2, 2026
Sportpharm LLCMETHOCARBAMOL 750 mg/1Jul 15, 2026Sep 2, 2026
St. Mary's Medical Park PharmacyMETHOCARBAMOL 750 mg/1Jul 15, 2026Sep 2, 2026
Unichem Pharmaceuticals (Usa), Inc.METHOCARBAMOL 750 mg/1Jul 15, 2026Sep 2, 2026
Unichem Pharmaceuticals (Usa), Inc.METHOCARBAMOL 500 mg/1Jul 15, 2026Sep 2, 2026
A-S Medication SolutionsMETHOCARBAMOL 500 mg/1Jul 15, 2026Aug 31, 2026
PD-Rx Pharmaceuticals, Inc.METHOCARBAMOL 500 mg/1Jul 15, 2026Aug 31, 2026
Medcore LLCMETHOCARBAMOL 500 mg/1Aug 1, 2026Aug 29, 2026
Medcore LLCMETHOCARBAMOL 750 mg/1Aug 1, 2026Aug 29, 2026
PD-Rx Pharmaceuticals, Inc.METHOCARBAMOL 750 mg/1Jul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Methocarbamol Tablets, USP, 500 mg — NDC 10135-0722-01," retrieved September 3, 2026, https://drugdashboards.com/drug/10135072201.

Free to cite with attribution — see how the data is put together.